Abstract

Objective: In this study, we analyzed the existing chin augmentation methods and evaluated the effectiveness of using a subplatysmal fat autograft for augmenting insufficient chin projection. Materials and Methods: From January 2017 to December 2023, we studied 170 patients at the Department of Plastic Surgery, Sechenov First Moscow State Medical University, who presented with insufficient chin projection, localized fat deposits in the cervico-mental area, and age-related changes in the lower third of the face. The patients were divided into two groups: Group 1 (n = 93) consisted of patients who underwent chin augmentation using implants (Silastic, Medpor); Group 2 (n = 77) included patients who underwent medial platysmaplasty and chin augmentation using a fat autograft (subplatysmal autograft). Results: Chin augmentation was performed on all the patients with varying degrees of insufficient chin projection. The mean age was 36.5 ± 2 years. The average follow-up period was 18.9 months (range: 2–45 months). For chin augmentation using implants (Silastic, Medpor), +chin projection increases were observed as follows: 1.1–1.2 cm at 3 months, 0.9–2.3 cm at 6 months, and 0.8–1.7 cm at 12 months. The complications in this group included inflammatory processes in 7 (8%) patients, hematomas in 6 (6%) patients, and contour asymmetry in 13 (14%) patients. In the group that underwent chin augmentation with a subplatysmal fat autograft, the chin projection increased by 0.8–1.2 cm at 3 months, 0.7–1.3 cm at 6 months, and 0.6–1.9 cm at 12 months. The mean age was 38.3 ± 7 years, with an average follow-up of 18.3 months (range: 2–43 months). No infectious–inflammatory complications were observed. Aesthetic complications were noted in 14 (18%) patients. Conclusions: Among the existing methods for chin augmentation, many still consider osseous genioplasty to give more predictable results. However, its traumatic nature and lengthy rehabilitation period prompt surgeons to seek effective yet less invasive alternatives. When selecting a minimally invasive method for chin augmentation, preference is given to fat injections (lipofilling) and intraoperative use of autologous fat grafts. Augmentation using subplatysmal autologous fat grafts is a minimally invasive, safe, predictable, and long-lasting method for chin correction.

Abstract

Background Pseudogynecomastia in MWL patients is characterized by excess skin in chest, lateral chest, axilla and upper abdomen without enlargement of the breast glandular component. The aim of this work was to study long-term aesthetic outcomes of correction of severe pseudogynecomastia post-weight loss with inferior pedicle technique with some refinements.

Methodology This prospective study included 15 patients underwent chest contouring after massive weight loss within period of 2 years between January 2022 and January 2024. All patients were subjected to local examination (position of nipple–areola complex and degree of ptosis and chest anthropometry) and photographic assessment, and pre- and postoperative results were compared. Patient satisfaction survey was done.

Results The ages ranged from 20 to 45 years (mean 32.67 years), the previous weight ranged with mean 158.8, the mean current weight was 87.53, and the mean BMI was 28.49. The time of weight loss ranged from 8 to 48 months (mean 20.07 months), and the duration of weight stability

ranged from 6 to 24 months with mean 10.0 months. Regarding the complications, no major complications required readmission, four patients had minor complications (26.7%), one (6.7%) case had asymmetry of the NAC, one (6.7%) case had minor hematoma, one (6.7%) case had

seroma, and one (6.7%) case had partial wound dehiscence. The overall satisfaction rate was high.

Conclusion Patient satisfaction with male chest contouring for pseudogynecomastia following significant weight loss is excellent. In this study, we provide a reliable technique for management of pseudogynecomastia in post-MWL with good outcomes

Abstract

Facial aesthetic surgery procedures are often the final stage in the treatment of complex craniofacial deformities. However, they can also complement routine plastic surgery procedures of the face.

Material and Methods

A retrospective study was conducted, including patients who underwent facial surgery between April 2022 and February 2025.

Results

The study included 399 patients: 275 cisgender women, 35 transgender women, 84 cisgender men, and 5 transgender men. Among women, the most frequently performed procedures were surgical facelift and neck lift, eyelid surgery (blepharoplasty), brow lift, genioplasty for aesthetic indications or camouflage after orthodontic treatment, chin implant, submental liposuction, buccal fat removal (bichectomy), surgical correction of malocclusion, and rhinoplasty. Among transgender women, the main procedures performed included osteoplasty of the upper facial third, hairline advancement, hair transplantation, brow lift, mandibular angle reduction, genioplasty, thyroid cartilage reduction (tracheal shave), and rhinoplasty. Among men and transgender men, the most common procedures were jaw angle implants, chin implants, genioplasty, hair transplantation, facelift and neck lift, and thyroid cartilage augmentation. In 82.5% of the studied patient population, combined procedures involving at least two interventions were performed, while only 17.5% of patients underwent single procedures.

Abstract

Shingles, also known as herpes zoster (HZ), is a serious health concern, particularly among older adults. In Southeast Asia, knowledge gaps and low vaccination rates contribute to a significant disease burden. The 2023 Zoster Experts’ Network (ZEN) Workshop, involving Indonesia, Malaysia, the Philippines, Thailand, and Vietnam, observed lack of knowledge in HZ awareness among patients and healthcare professionals. This lack of knowledge translates into low vaccination uptake, which is further exacerbated by socioeconomic barriers. Consequently, a considerable portion of the population remains vulnerable to HZ and its complications, such as postherpetic neuralgia.  The ZEN workshop emphasized the need for public awareness campaigns and the integration of HZ vaccination into national immunization programs. The Indonesian Society of Internal Medicine (PAPDI) updated its adult immunization schedule in 2024 to include the HZ recombinant vaccine align with ZEN countries.  The availability of recombinant HZ vaccines in Indonesia could be offers a valuable means for implementing these recommendations. This step underscores the importance of HZ prevention in the Indonesian healthcare context, especially given the country’s growing elderly population. To effectively implement these recommendations and maximize protection against HZ, a multi-pronged approach is crucial. This includes public health education campaigns to raise awareness and address misconceptions, healthcare provider training to ensure proper diagnosis and vaccination practices, and strategies to improve vaccine affordability and accessibility. By integrating these efforts, Indonesia can significantly reduce the burden of HZ and improve the quality of life for its aging population